🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalSwitzerland BAG coverage — 12 month update Page 3

Switzerland BAG coverage — 12 month update

SarahChen_PharmD Mon, Feb 2, 2026 at 5:10 PM 29 replies 1,533 viewsPage 3 of 6
InsuranceTom
Senior Member
1,345
7,890
Mar 2024
Connecticut
Feb 3, 2026 at 1:21 AM#11
pat_auckland said:
Insurance update relevant to cost and coverage: I just got my prior auth approved through Cigna after 4 attempts.
pat_auckland said:
...my insurance denied cost and coverage coverage because...

Insurance denial is the single biggest barrier to GLP-1 access. Let me share the appeal framework that worked for me and several community members:

  1. Document medical necessity (BMI, comorbidities, failed alternatives)
  2. Reference clinical practice guidelines (AGA, AACE, Endocrine Society)
  3. Cite cost-effectiveness data (preventing diabetes/surgery saves money long-term)
  4. Request peer-to-peer review between your doctor and the plan's medical director
  5. File external appeal with your state insurance department if internal appeal fails

Don't accept the first denial. The appeal process exists for a reason.

45 18lisa_labSD, adam_van, Dr.SurgeonPGH and 42 others
Reply Quote Save Share Report
tony_orlando
Member
234
1,123
Nov 2024
Orlando, FL
Feb 3, 2026 at 3:38 AM#12
labquiet_amy said:
Dr.SurgeonPGH said: ...regarding the discontinuation data for cost and coverage...

This answered a question I did not know how to ask. I will report back once I have actually tried it.

46 19JakeSmashed95, NauseaFreeNow, SteveThurs and 43 others
Reply Quote Save Share Report
JenPlateau
Member
234
890
Nov 2024
Missouri
Feb 3, 2026 at 5:55 AM#13
pat_auckland said:
Insurance update relevant to cost and coverage: I just got my prior auth approved through Cigna after 4 attempts.

My insurance denied my PA related to cost and coverage. Has anyone successfully appealed? I'm considering going compounded instead.

Last edited: Feb 3, 2026 at 11:55 AM
47 20RunnerRach, TrialNerd_Beth, HPLC_Greg and 44 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
VendorMark
Senior Member
3,456
14,567
Jan 2024
Texas
Online
Feb 3, 2026 at 8:12 AM#14
SarahChen_PharmD said:
The list price and the price I actually pay differ by a factor of six depending on which of four routes I use, and none of that is transparent from…

Insurance coverage hack for cost and coverage: if your insurance denies brand Wegovy/Ozempic, consider these alternatives:

  1. Prior authorization appeal with peer-to-peer review
  2. Manufacturer copay card (for commercial insurance)
  3. Patient assistance programs (Novo Nordisk, Eli Lilly)
  4. Compounded medication from a 503B pharmacy ($112/month)
  5. Canadian pharmacy (requires prescription, ~40-60% savings)

Don't let cost prevent access to effective treatment. There are options at every price point.

48 21Dr.PeteFamMed, claudia_zurich, nancy_portland and 45 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Feb 3, 2026 at 10:29 AM#15

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful.

Last edited: Feb 3, 2026 at 2:29 PM
49 22PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 46 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register